Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

OKYO Pharma Limited (OKYO)

Compare
1.2200
+0.1100
+(9.91%)
At close: April 17 at 4:00:00 PM EDT
1.1732
-0.05
(-3.84%)
After hours: April 17 at 6:52:46 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Expense
15,749.7320
15,749.7320
13,187.2000
6,217.5660
3,366.2060
Operating Income
-15,749.7320
-15,749.7320
-13,187.2000
-6,217.5660
-3,366.2060
Net Non Operating Interest Income Expense
-1,053.3130
-1,053.3130
-96.6870
--
-1.1230
Other Income Expense
--
--
--
--
-11.1720
Pretax Income
-16,803.0450
-16,803.0450
-13,283.8870
-6,217.5660
-3,378.5010
Tax Provision
22.4160
22.4160
-12.2020
-786.5210
-24.9940
Net Income Common Stockholders
-16,825.4610
-16,825.4610
-13,271.6850
-5,431.0450
-3,353.5070
Diluted NI Available to Com Stockholders
-16,825.4610
-16,825.4610
-13,271.6850
-5,431.0450
-3,353.5070
Basic EPS
-0.57
-0.57
-0.61
-0.36
-0.32
Diluted EPS
-0.57
-0.57
-0.61
-0.36
-0.32
Basic Average Shares
29,343.7270
29,343.7270
22,257.0580
15,064.8130
10,350.2710
Diluted Average Shares
29,343.7270
29,343.7270
22,257.0580
798,259.3560
10,350.2710
Total Operating Income as Reported
--
--
--
--
-4,133.3498
Total Expenses
15,749.7320
15,749.7320
13,187.2000
6,217.5660
3,366.2060
Net Income from Continuing & Discontinued Operation
-16,825.4610
-16,825.4610
-13,271.6850
-5,431.0450
-3,353.5070
Normalized Income
-16,825.4610
-16,825.4610
-13,271.6850
-5,431.0450
-3,342.4176
Interest Expense
1,053.3130
1,053.3130
96.6870
--
1.1230
Net Interest Income
-1,053.3130
-1,053.3130
-96.6870
--
-1.1230
EBIT
-15,749.7320
-15,749.7320
-13,187.2000
-6,217.5660
-3,377.3780
EBITDA
-15,745.8660
-15,745.8660
-13,183.4030
-6,215.2350
-3,364.2670
Reconciled Depreciation
3.8660
3.8660
3.7970
2.3310
13.1110
Net Income from Continuing Operation Net Minority Interest
-16,825.4610
-16,825.4610
-13,271.6850
-5,431.0450
-3,353.5070
Total Unusual Items Excluding Goodwill
--
--
--
--
-11.1720
Total Unusual Items
--
--
--
--
-11.1720
Normalized EBITDA
-15,745.8660
-15,745.8660
-13,183.4030
-6,215.2350
-3,353.0950
Tax Rate for Calcs
0.0003
0.0003
0
0.0001
0
Tax Effect of Unusual Items
--
--
--
--
-0.0826
3/31/2021 - 5/17/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

603439.SS Guizhou Sanli Pharmaceutical Co.,Ltd
12.51
-0.40%
 
GENFF Genflow Biosciences plc
0.0170
0.00%
 
WQ5.F Genflow Biosciences plc
0.0115
0.00%
 
IMTXW Immatics N.V.
0.0134
+7.20%
 
CYCCP Cyclacel Pharmaceuticals, Inc.
4.5900
+9.03%
 
TLSA Tiziana Life Sciences Ltd
1.0700
+20.22%
 
ICUCW SeaStar Medical Holding Corporation
0.0357
-3.51%
 
CYCN Cyclerion Therapeutics, Inc.
2.7500
+2.61%
 
ACUT AccuStem Sciences, Inc.
0.5600
+27.27%
 
MLEC Moolec Science SA
0.6762
-6.08%